Full Text
Full text is available in PDF
Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT
1Department of Nuclear Medicine and PET-CT,Jaslok hospital and Research Centre, drprathamj@gmail.com, India
*Corresponding Author: Department of Nuclear Medicine and PET-CT, Jaslok hospital and Research Centre, Worli, drprathamj@gmail.com, India. Tel: +98-912266573244. Fax: +98-912266573244. Email: drprathamj@gmail.com
Published online:Mar 01, 2012
Article type:Case Report
Received:Sep 11, 2011
Accepted:Oct 11, 2011
Abstract
We report a case of prostatic adenocarcinoma, initially presenting with generalized lymphadenopathy, and mimicking lymphoma on flurodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT). our case suggests that in elderly men presenting with generalized lymphadenopathy, the diagnosis of metastatic prostatic carcinoma should not be overlooked even in the absence of typical urinary symptoms.The establishment of a diagnosis of metastatic prostate carcinoma is important, because even widespread prostate cancer may be responsive to hormonal treatment, as demonstrated by this case.We also describe the use of FDG PET/CT to diagnose, stage, and evaluate response to hormonal treatment in a given patient.
Highlights
How to Cite:Joshi P, Lele V. Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT. Nephro-Urol Mon. 2012;4(2):. doi: https://doi.org/10.5812/numonthly.2303
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
24
Sep
2012
FDG PET/CT in Prostate Cancer: A Valuable Method to Detect the Primary and Metastatic Tumor Sites and to Monitor Cancer Response to Hormonal Therapy
Alexander Hinev,
Borislav Chaushev,
Aneliya Klisarova
Hinev A, Chaushev B, Klisarova A. FDG PET/CT in Prostate Cancer: A Valuable Method to Detect the Primary and Metastatic Tumor Sites and to Monitor Cancer Response to Hormonal Therapy. Nephro-Urol Mon. 2012;4(4):644-645. doi: https://doi.org/10.5812/numonthly.4539
1
Mar
2014
Role of Positron Emission Tomography–Computed Tomography in Pulmonary Neoplasms
Mehrdad Bakhshayeshkaram
Bakhshayeshkaram M. Role of Positron Emission Tomography–Computed Tomography in Pulmonary Neoplasms. I J Radiol. 2014;11(30th Iranian Congress of Radiology):e93645. doi: https://doi.org/10.5812/iranjradiol.21330
19
May
2022
Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients
Abtin Doroudinia,
Najmeh Darvishian,
Mehrdad Bakhshayesh Karam,
Habib Emami
Doroudinia A, Darvishian N, Bakhshayesh Karam M, Emami H. Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients. I J Radiol. 2022;19(1):e122440. doi: https://doi.org/10.5812/iranjradiol-122440
31
Oct
2021
Gallium-68-Labeled Prostate-Specific Membrane Antigen (68Ga-PSMA) Uptake in Renal Cell Carcinoma and Lung Adenocarcinoma: A Case Report
Abtin Doroudinia,
Payam Mehrian,
Maedeh Forghani
Doroudinia A, Mehrian P, Forghani M. Gallium-68-Labeled Prostate-Specific Membrane Antigen (68Ga-PSMA) Uptake in Renal Cell Carcinoma and Lung Adenocarcinoma: A Case Report. I J Radiol. 2021;18(4):e115962. doi: https://doi.org/10.5812/iranjradiol.115962
12
Apr
2017
The Role of 18F FDG PET/CT in Clinical Management of Breast Cancer; Additional Value Over Conventional Imaging Modalities
Mehrdad Bakhshayeshkaram,
Farahnaz Aghahosseini,
Abtin Doroudinia
Bakhshayeshkaram M, Aghahosseini F, Doroudinia A. The Role of 18F FDG PET/CT in Clinical Management of Breast Cancer; Additional Value Over Conventional Imaging Modalities. I J Radiol. 2017;14(Special Issue):e47975. doi: https://doi.org/10.5812/iranjradiol.47975
Cited by
- Scopus by DOI: 2
Last Update: 1 month ago
- Scopus by Title: 2
Last Update: 1 month ago
- Scopus by Title (Ref): 2
Last Update: 1 month ago
- CrossRef: 3
Last Update: 4 days ago
- OpenAlex: 4
Last Update: 2 days ago
- OpenCitations: 4
Last Update: 2 days ago
Comments
Number of Comments:0Indexed in
